WilliamKennethWardMD
Endocrinology • Portland, ORDiabetes, Lipid Metabolism
Associate Professor, Medicine, Oregon Health and Science University School of Medicine
Dr. Ward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Mailcode Op05dc
Portland, OR 97239Phone+1 503-494-5732
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1983
University of ColoradoResidency, Internal Medicine, 1978 - 1981- University of Colorado School of Medicine Anschutz Medical CampusClass of 1978
Certifications & Licensure
OR State Medical License 1986 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone Start of enrollment: 2008 Nov 01
- Continuous Glucose Monitoring to Measure Effect of Glycemic Index Start of enrollment: 2009 Apr 01
- Real-time Adaptation to Changes in Insulin Sensitivity Start of enrollment: 2010 Nov 01
Publications & Presentations
PubMed
- 1170 citationsQuantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.Steven E. Kahn, Ronald L. Prigeon, David K. McCulloch, Edward J. Boyko, Richard N. Bergman
Diabetes. 1993-11-01 - 29 citationsStable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreasMelanie A. Jackson, Nicholas Caputo, Jessica R. Castle, Larry L. David, Charles T. Roberts
Current Diabetes Reports. 2012-09-13 - 19 citationsIn vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effect.W. Kenneth Ward, Ryan G. Massoud, Cory Szybala, Julia M. Engle, Joseph El Youssef
Journal of Diabetes Science and Technology. 2010-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
